Expression of vascular endothelial growth factor in diffuse malignant pleural mesothelioma

Virchows Archiv

Volumn 435, Issue 1, 1999, Pages 8-12

  König, Jens Ekkehard ^a   Tolnay, Edina ^b   Wiethege, Thorsten ^a   Müller, Klaus Michael ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Diffuse malignant pleural mesothelioma; Factor VIII; Histological differentiation; Microvessel count; Vascular endothelial growth factor

Indexed keywords

ANTIBODY; BLOOD CLOTTING FACTOR 8; MESSENGER RNA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOKINES; MACROPHAGES; MALE; MESOTHELIOMA; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PLEURAL NEOPLASMS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032810868     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050388     Document Type: Article

References (22)

1. 1. Brockmann M (1992) Malignes diffuses Pleuramesotheliom -Heterogenität, Differentialdiagnose und Histogenese. Hauptverband der gewerblichen Berufsgenossenschaften, Sankt Augustin
2. 2. Brown LF, Berse B, Jackman RF, Tognazzi K, Manseau E, Dvorak H, Senger DR (1993) Increased expression of VPF and its receptors in kidney and bladder carcinoma. Am J Pathol 143:1255-1262
3. 3. Brown LF, Berse B, Jackman RF, Tognazzi K, Manseau E, Dvorak H, Senger DR (1993) Expression of vascular permeability factor (VEGF) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53:4727-4735
4. 4. Cordell JL, Fallini B, Erber WN (1984) Immunoenzymatic labeling of monoclonal antibodies using immunocomplexes of alkaline phosphatase and monoklonal anti-alkaline phosphatase (APAAP) complexes. J Histochem Cytochem 32:219-229
5. 5. Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA, Janice A, Sotrel A, Manseau EJ, Van De Water L, Senger DR (1991) Distribution of vascular permeability factor in tumours: concentration in tumour blood vessels. J Exp Med 174:1275-1278
6. 6. Ferrara N, Houck K, Jakema L (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins. J Endocrinol 13:18-32
7. 7. Fisseler-Eckhoff A, Rothstein D, Müller K-M (1996) Neovascularization in hyperplastic, metaplastic and potentially preneoplastic lesions of the bronchial mucosa. Virchows Arch 429:95-100
8. 8. Folkman J (1995) Tumour angiogenesis. In: Mendelson J (ed) The molecular basis of cancer. Saunders, Philadelphia, London, Toronto, pp 207-232
9. 9. Goto F, Weindel K (1993) Synergistic effects of VEGF on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 69:508-514
10. 10. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumourigenesis. Cell 86:353-364
11. 11. Jones JSP (1993) The formation and function of the mesothelioma panel of the Commission of the European Community. (Health and safety series, EUR 14522) Office for official publications of the European Communities, Luxembourg
12. 12. Jones JSP, Brachet EA, Butler EB (1987) The pleura and its pathology. In: Jones JSP (ed) Pathology of the mesothelium. Springer, London Berlin Heidelberg, pp 39-133
13. 13. Kumar-Singh S, Jacobs W, Dhaene K, Weyn B, Bogers J, Weyler J, Van Mark E (1998) Syndecan-1 expression in malignant mesothelioma - correlation with cell differentiation, WT1 expression and clinical outcome. J Pathol 186:300-305
14. 14. Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848
15. 15. Shweiki D, Itin A, Neufeld G (1993) Patterns of expression of VEGF and receptors in mice suggest a role in hormonally regulated angiogenesis. Clin Invest 91:2235-2236
16. 16. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55:3964-3968
17. 17. Tolnay E, Wiethege TH, Kuhnen C, Wulf M, Voss B, Müller K-M (1997) Expression of type IV collagenase correlates with the expression of VEGF in primary non-small cell lung cancer. Cancer Res Clin Oncol 123:652-658
18. 18. Tolnay E, Kuhnen K, Wiethege T, König JE, Voss B, Müller KM (1998) Hepatocyte growth factor/scatter factor and ist receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma. J Cancer Res Clin Oncol 124:291-296
19. 19. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E (1999) Histological typing of lung and pleural tumors. World Health Organization. International histological classification of tumours. 3rd edn. Springer, Berlin, pp 51-54
20. 20. Weidner N (1995) Intratumour microvessel density as a prognostic factor in cancer. Am J Pathol 147:9-19
21. 21. Wiethege TH, Voss B, Pohle T, Fisseler-Eckhoff A, Müller K-M (1991) Localization of elastase and tumour necrosis factor alpha mRNA by non-radioactive in situ hybridization in cultures of alveolar macrophages. Pathol Res Pract 187:912-915
22. 22. Yeo K, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF, Yeo T (1993) Vascular permeability factor (VEGF) in guinea pig and human tumour and inflammatory effusion. Cancer Res 53:2912-2918